Amarantus Bioscience Holdings, Inc.
(Other OTC/NBB : AMBS)

( )
AMBS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading AMBS News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.28%82.501.8%$747.72m
BIIBBiogen Inc.
0.04%239.001.0%$575.11m
CELGCelgene Corporation
0.26%99.071.2%$474.86m
AMGNAmgen Inc.
0.60%151.001.0%$444.75m
REGNRegeneron Pharmaceuticals, Inc.
0.00%347.863.1%$327.86m
ALXNAlexion Pharmaceuticals, Inc.
0.00%114.172.5%$297.15m
ILMNIllumina, Inc.
0.00%137.584.9%$165.30m
VRTXVertex Pharmaceuticals Incorporated
0.00%85.002.6%$133.57m
MDVNMedivation, Inc.
0.00%60.952.8%$132.33m
BMRNBioMarin Pharmaceutical Inc.
0.00%78.374.0%$128.24m
TSROTESARO, Inc.
-3.44%74.7415.8%$109.34m
SRPTSarepta Therapeutics, Inc.
-0.86%18.5049.4%$105.01m
AAgilent Technologies, Inc.
0.00%43.761.0%$102.88m
CPXXCelator Pharmaceuticals, Inc.
0.00%30.218.5%$102.09m
ACADACADIA Pharmaceuticals Inc.
0.00%32.3819.6%$97.26m

Company Profile

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.